MacroGenics Inc at Stifel Virtual Healthcare Conference Transcript
Hello, everyone. I'm Stephen Willey, one of the senior biotech analysts here at Stifel. Glad to have with us here this morning, presenting from MacroGenics is the Chief Executive Officer, Scott Koenig. He is going to -- we're just going to have an informal discussion here. I think that there's a chat function for anyone who's listening to populate some questions into, and we can get those asked and answered, I guess, as appropriate.
But Scott, I guess, before we get into Q&A, any kind of opening statements you want to make just with respect to kind of who you are, what you do and where you are?
Thanks, Steve, and appreciate the invitation today. It's a very exciting time for the company. As you know, we've made tremendous progress during the year. Currently, we have 8 molecules in clinical development, Phase I to Phase III, have a very large preclinical portfolio. Our molecules are using
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
